Free Trial
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free VOR Stock Alerts

Vor Biopharma (VOR) News Today

Vor Biopharma logo
$14.63 -0.44 (-2.92%)
Closing price 04:00 PM Eastern
Extended Trading
$14.93 +0.30 (+2.05%)
As of 04:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

VOR Latest News

We're Hopeful That Vor Biopharma (NASDAQ:VOR) Will Use Its Cash Wisely
 |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/were-hopeful-vor-biopharma-nasdaq-122530613.html
Vor Biopharma (NASDAQ:VOR) Price Target Raised to $18.00 at Wedbush
May 15 at 4:11 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30779547
Analysts Are Bullish on These Healthcare Stocks: Protara Therapeutics (TARA), Vor Biopharma (VOR)
May 14 at 8:53 PM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/1939301/analysts-are-bullish-on-these-healthcare-stocks-protara-therapeutics-tara-vor-biopharma-vor/
Vor Bio Announces Publication of Interim Analysis of TELIGAN, a China Phase 3 Trial of Telitacicept in IgA Nephropathy, in The New England Journal of Medicine
May 14 at 8:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/14/3294940/0/en/vor-bio-announces-publication-of-interim-analysis-of-teligan-a-china-phase-3-trial-of-telitacicept-in-iga-nephropathy-in-the-new-england-journal-of-medicine.html
Vor Biopharma: Vor Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 13 at 3:10 PM  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-05/68485553-vor-biopharma-vor-bio-reports-first-quarter-2026-financial-results-and-provides-corporate-update-399.htm
Vor Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 13 at 8:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/13/3294002/0/en/vor-bio-reports-first-quarter-2026-financial-results-and-provides-corporate-update.html
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/04/3287173/0/en/vor-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4.html
Jefferies Financial Group Upgrades Vor Biopharma (NASDAQ:VOR) to Strong-Buy
May 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/jefferies-financial-group-upgrades-vor-biopharma-nasdaqvor-to-strong-buy-2026-05-01/
Vor Biopharma Inc. (NASDAQ:VOR) Receives Consensus Rating of "Moderate Buy" from Brokerages
May 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/vor-biopharma-inc-nasdaqvor-receives-consensus-rating-of-moderate-buy-from-brokerages-2026-05-01/
Vor Biopharma Inc. (NASDAQ:VOR) Short Interest Down 17.3% in April
April 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/vor-biopharma-inc-nasdaqvor-short-interest-down-173-in-april-2026-04-30/
Vor Biopharma (NASDAQ:VOR) Director Ra Capital Management, L.P. Sells 165,150 Shares
April 24, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/vor-biopharma-nasdaqvor-director-ra-capital-management-lp-sells-165150-shares-2026-04-24/
Vor Biopharma (NASDAQ:VOR) Director Sells $2,711,856.51 in Stock
April 22, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-vor-insider-buying-and-selling-2026-04-22/
Insider Selling: Vor Biopharma (NASDAQ:VOR) Director Sells 171,963 Shares of Stock
April 21, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-selling-vor-biopharma-nasdaqvor-director-sells-171963-shares-of-stock-2026-04-21/
Vor Biopharma (NASDAQ:VOR) Director Sells $7,462,931.08 in Stock
April 21, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/vor-biopharma-nasdaqvor-director-sells-746293108-in-stock-2026-04-21/
Vor Biopharma (NASDAQ:VOR) Shares Down 4.4% - Here's What Happened
April 20, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/vor-biopharma-nasdaqvor-shares-down-44-heres-what-happened-2026-04-20/
Vor Biopharma (NASDAQ:VOR) Trading 9.7% Higher - What's Next?
April 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/vor-biopharma-nasdaqvor-trading-97-higher-whats-next-2026-04-17/
Vor Biopharma Q1 EPS Estimate Increased by HC Wainwright
April 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/vor-biopharma-q1-eps-estimate-increased-by-hc-wainwright-2026-04-17/
Ra Capital Management, L.P. Sells 53,644 Shares of Vor Biopharma (NASDAQ:VOR) Stock
April 16, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-vor-insider-buying-and-selling-2026-04-16/
Ra Capital Management, L.P. Sells 530,610 Shares of Vor Biopharma (NASDAQ:VOR) Stock
April 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/ra-capital-management-lp-sells-530610-shares-of-vor-biopharma-nasdaqvor-stock-2026-04-15/
Vor Biopharma (NASDAQ:VOR) Director Sells $858,840.44 in Stock
April 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/vor-biopharma-nasdaqvor-director-sells-85884044-in-stock-2026-04-15/
Insider Selling: Vor Biopharma (NASDAQ:VOR) Director Sells 153,735 Shares of Stock
April 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-selling-vor-biopharma-nasdaqvor-director-sells-153735-shares-of-stock-2026-04-15/
HC Wainwright Has Lowered Expectations for Vor Biopharma (NASDAQ:VOR) Stock Price
April 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/hc-wainwright-has-lowered-expectations-for-vor-biopharma-nasdaqvor-stock-price-2026-04-15/
Ra Capital Management, L.P. Sells 828 Shares of Vor Biopharma (NASDAQ:VOR) Stock
April 11, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-vor-insider-buying-and-selling-2026-04-11/
Vor Biopharma: It's A Game Of Wait And See
April 8, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4889327-vor-biopharma-its-a-game-of-wait-and-see
Vor Biopharma (NASDAQ:VOR) Director Sells $4,739,800.00 in Stock
April 7, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-vor-insider-buying-and-selling-2026-04-07/
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/01/3267042/0/en/vor-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4.html
Jefferies initiates coverage of Vor Biopharma (VOR) with buy recommendation
March 31, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/jefferies-initiates-coverage-of-vor-biopharma-vor-with-buy-recommendation/ar-AA1ZMSen
Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/30/3264589/0/en/vor-bio-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-corporate-update.html
Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjögren's Disease
March 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/30/3264556/0/en/vor-bio-doses-first-patient-in-global-phase-3-upstream-sjd-registrational-trial-of-telitacicept-in-primary-sj%c3%b6gren-s-disease.html
What's behind the jump in Vor Biopharma stock?
March 27, 2026  |  msn.comhttps://www.msn.com/en-us/money/news/what-s-behind-the-jump-in-vor-biopharma-stock/ar-AA1Zyb3C
What's Behind The Jump In Vor Biopharma Stock?
March 27, 2026  |  benzinga.comhttps://www.benzinga.com/trading-ideas/movers/26/03/51512510/whats-behind-the-jump-in-vor-biopharma-stock
Vor Biopharma Announces $75 Million Private Placement Financing
March 27, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/vor-biopharma-announces-75-million-private-placement-financing?utm_source=marketbeat.com&utm_medium=referral
Vor Bio Announces $75 Million Private Placement with TCGX
March 27, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/27/3263720/0/en/vor-bio-announces-75-million-private-placement-with-tcgx.html
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/23/3260855/0/en/vor-bio-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html
Wells Fargo initiates coverage of Vor Biopharma (VOR) with overweight recommendation
March 20, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/wells-fargo-initiates-coverage-of-vor-biopharma-vor-with-overweight-recommendation/ar-AA1Z2ySA
Vor Biopharma Inc.
March 7, 2026  |  barrons.comhttps://www.barrons.com/market-data/stocks/vor/company-people?gaa_n=AWEtsqfFs7avqNkAk85Io5cOwMW91Dk8mSbMAGowSaUjIVJWWjUx0OVhOd8d&gaa_ts=69a9d6f3
Vor Biopharma Inc. (VOR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
March 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4879333-vor-biopharma-inc-vor-presents-at-td-cowen-46th-annual-health-care-conference-transcript
Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference
February 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/23/3242580/0/en/vor-bio-to-participate-in-the-46th-annual-td-cowen-health-care-conference.html
Vor Biopharma earns relative strength rating upgrade
February 11, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/vor-biopharma-earns-relative-strength-rating-upgrade/ar-AA1W8SRz
Vor Biopharma earns relative strength rating upgrade; hits key benchmark
February 9, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/vor-biopharma-earns-relative-strength-rating-upgrade-hits-key-benchmark/ar-AA1VZGnw
Vor Biopharma (VOR) price target decreased by 10.34% to 37.13
January 14, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/vor-biopharma-vor-price-target-decreased-by-10-34-to-37-13/ar-AA1UeHlo
Citigroup initiates coverage of Vor Biopharma (VOR) with buy recommendation
January 9, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/citigroup-initiates-coverage-of-vor-biopharma-vor-with-buy-recommendation/ar-AA1TUSqX
Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/01/06/3213559/0/en/vor-bio-to-participate-in-the-44th-annual-j-p-morgan-healthcare-conference.html
Vor Biopharma CDO Departs, Transition Support Planned
January 4, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/VOR/pressreleases/36872865/vor-biopharma-cdo-departs-transition-support-planned/
Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors
December 23, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/vor-bio-appoints-ra-capital-s-andrew-levin-m-d-ph-d-and-forbion-s-wouter-joustra-to-board-of-directors-1035668697
Vor Biopharma Inc. Appoints Andrew Levin and Wouter Joustra to Board of Directors Following $150M PIPE Financing
December 23, 2025  |  quiverquant.comQ
Vor Bio Appoints RA Capital's Andrew Levin, M.D., Ph.D., and Forbion's Wouter Joustra to Board of Directors
December 23, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/12/23/3210128/0/en/vor-bio-appoints-ra-capital-s-andrew-levin-m-d-ph-d-and-forbion-s-wouter-joustra-to-board-of-directors.html
Vor Biopharma: Initiating Hold Rating On Durable Telitacicept MG Study Data
December 17, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4854215-vor-initiating-hold-rating-on-durable-telitacicept-mg-study-data
Stocks to watch: Vor Biopharma sees RS rating jump to 89
December 17, 2025  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/stocks-to-watch-vor-biopharma-sees-rs-rating-jump-to-89/ar-AA1SwUyl
Vor Bio announces $150M private placement
December 15, 2025  |  msn.comhttps://www.msn.com/en-us/money/general/vor-bio-announces-150m-private-placement/ar-AA1SnQ33
Get Vor Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for VOR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VOR Media Mentions By Week

VOR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VOR
News Sentiment
▼
-0.01

0.99
▲
Average
Manufacturing
News Sentiment

VOR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VOR Articles
This Week
▼
8

5
▲
VOR Articles
Average Week

Get the Latest News and Ratings for VOR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Vor Biopharma and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
Headlines Tools

This page (NASDAQ:VOR) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel